Mirae Asset Global Investments
BEAT

Mirae Asset Global Investments’s BioTelemetry, Inc. BEAT Stock Holding History

Mirae Asset Global Investments’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-158,897
Closed -$11.5M – 1686
2020
Q4 		$11.5M Buy
158,897
+42,557
+37% +$2.23M 0.04% 457
2020
Q3 		$5.3M Buy
+116,340
New +$4.86M 0.03% 538

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Mirae Asset Global Investments's BEAT Position: Q1 2021 in Review

Mirae Asset Global Investments sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 158,897 shares — an estimated $11.5M sold.

Mirae Asset Global Investments first reported a position in BEAT in Q3 2020 and held it in 2 quarters. The position peaked at $11.5M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Mirae Asset Global Investments reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Mirae Asset Global Investments sold 158,897 BioTelemetry, Inc. shares in Q1 2021, an estimated $11.5M.
  • Mirae Asset Global Investments first reported a position in BioTelemetry, Inc. in Q3 2020 and held it in 2 quarters.
  • Mirae Asset Global Investments's BioTelemetry, Inc. position peaked at $11.5M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Mirae Asset Global Investments's 13F filing for Q1 2021, filed 13 May 2021.